Company intelligence / Profile preview

PNA Bio

Thousand Oaks, California, USA

Ownership: Private
Development stage: Other

Overview

PNA Bio is a biotechnology company specializing in the design and synthesis of high-quality Peptide Nucleic Acids (PNA). PNAs are synthetic DNA mimics with a pseudopeptide backbone, offering superior binding affinity and stability compared to traditional DNA or RNA. The company provides custom PNA synthesis, PNA-based reagents for research, and specialized tools for applications such as FISH, telomere analysis, and gene regulation. PNA Bio serves the global life sciences community, supporting research in molecular biology, diagnostics, and therapeutic development.

Therapeutic areas: Rare DiseasesOncology
Modalities: Peptide nucleic acidSynthetic oligonucleotideBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on PNA Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PNA Bio.

Explore the full profile